771 related articles for article (PubMed ID: 31438973)
21. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
[TBL] [Abstract][Full Text] [Related]
22. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
23. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
24. EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses.
Naito T; Ushirogawa H; Fukushima T; Tanaka Y; Saito M
Virol J; 2019 Dec; 16(1):160. PubMed ID: 31856855
[TBL] [Abstract][Full Text] [Related]
25. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
26. Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma.
Yamada A; Yasunaga JI; Liang L; Zhang W; Sunagawa J; Nakaoka S; Iwami S; Kogure Y; Ito Y; Kataoka K; Nakagawa M; Iwanaga M; Utsunomiya A; Koh KR; Watanabe T; Nosaka K; Matsuoka M
Cancer Sci; 2024 Jan; 115(1):310-320. PubMed ID: 37950425
[TBL] [Abstract][Full Text] [Related]
27. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
28. Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.
Yasunaga J; Matsuoka M
Cancer Control; 2007 Apr; 14(2):133-40. PubMed ID: 17387298
[TBL] [Abstract][Full Text] [Related]
29. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
[TBL] [Abstract][Full Text] [Related]
30.
Otaguiri KK; Dos Santos DF; Slavov SN; Depieri LV; Palma PVB; Meirelles FV; Covas DT; da Silveira JC; Kashima S
AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1075-1082. PubMed ID: 30229663
[TBL] [Abstract][Full Text] [Related]
31. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
Renjifo B; Chou K; Soto Ramirez L; Garcia Vallejo F; Essex M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S146-53. PubMed ID: 8797717
[TBL] [Abstract][Full Text] [Related]
32. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
[TBL] [Abstract][Full Text] [Related]
33. Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.
Enose-Akahata Y; Vellucci A; Jacobson S
Front Microbiol; 2017; 8():2563. PubMed ID: 29312243
[TBL] [Abstract][Full Text] [Related]
34. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
[TBL] [Abstract][Full Text] [Related]
35. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
McGinn TM; Wei Q; Stallworth J; Fultz PN
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
[TBL] [Abstract][Full Text] [Related]
37. HTLV-1 Tax and adult T-cell leukemia.
Giam CZ; Jeang KT
Front Biosci; 2007 Jan; 12():1496-507. PubMed ID: 17127397
[TBL] [Abstract][Full Text] [Related]
38. Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity.
Kannagi M; Hasegawa A; Kinpara S; Shimizu Y; Takamori A; Utsunomiya A
Cancer Sci; 2011 Apr; 102(4):670-6. PubMed ID: 21219540
[TBL] [Abstract][Full Text] [Related]
39. Tumor immunity against adult T-cell leukemia.
Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
[TBL] [Abstract][Full Text] [Related]
40. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
Ando S; Hasegawa A; Murakami Y; Zeng N; Takatsuka N; Maeda Y; Masuda T; Suehiro Y; Kannagi M
J Immunol; 2017 Feb; 198(3):1210-1219. PubMed ID: 28011931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
